Infertility Markers in Serum, Urine, and Follicular Fluid
NCT ID: NCT00194220
Last Updated: 2015-09-30
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1235 participants
OBSERVATIONAL
2002-09-30
2013-02-28
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The purpose of this investigation is to assess if markers of oxidative stress that are known to be associated with other medical conditions can be detected in women undergoing infertility treatment and normal women of similar age. Oxidative stress may affect a woman's eggs or the follicular cells that surround and nurture them. Other markers of to be investigated include markers of cellular aging and DNA structural changes.
Presence of these markers will be compared in blood and urine samples taken during infertility treatment, and follicular fluid at the time of IVF (if applicable).
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Fertility in Healthy Premenopausal Women
NCT02772848
Correlation of Oxidative Stress and Oocyte Quality in Fertility Preservation
NCT05372549
Evaluation of the Relationship Between Oxidative Stress and Human Reproduction
NCT05575739
Study of Serum Levels of Oxidative Stress Markers in Ovarian Hyperstimulation Patients
NCT02202278
Looking for a Blood Epigenetic Signature to Predict Female Infertility
NCT06098495
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Infertility patients only:
1. Women undergoing infertility treatment (with or without in-vitro fertilization) at the University of Pennsylvania's PENN Fertility Care
2. Verified infertility diagnosis of any of the following:
* Endometriosis (minimal or mild)
* Endometriosis (moderate or severe)
* Tubal factor
* Hypogonadotrophic hypogonadism
* Polycystic ovary syndrome
* Diminished ovarian reserve
* Male factor
* Unexplained
* Healthy normal volunteers only:
1. Not undergoing infertility treatment
2. Not using hormonal contraception
Exclusion Criteria
* Post-menopausal
* Concurrent participation in investigational trial
* Other health problems which, in the opinion of the investigator, may affect participation
18 Years
50 Years
FEMALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Pennsylvania
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Kurt T Barnhart, MD, MSCE
Role: PRINCIPAL_INVESTIGATOR
University of Pennsylvania
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Pennsylvania Reproductive Research Unit
Philadelphia, Pennsylvania, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RRU011
Identifier Type: -
Identifier Source: secondary_id
706658
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.